Clinical Trials

Clinical Research at RVC

Retina Vitreous Center is active in Clinical Research since 2013 and participating in various clinical trials sponsored by NIH and Industry.

The DRCR Network (DRCR.net) is a collaborative network dedicated to facilitating multicenter clinical research of diabetic retinopathy, age-related macular degeneration (AMD), hereditary retinal degenerations and other retinal diseases.

The DRCR.net was formed in September 2002 and currently includes over 115 participating sites with over 400 physicians throughout the United States. The DRCR.net is funded by the National Eye Institute (NEI). The NEI is a part of the National Institutes of Health, which is the branch of government that funds medical research. Retina Vitreous Center is recognized as a Top Site for the year 2015 by the DRCR.net and the only private practice site in Oklahoma.

Dr. Shah, Dr Phelps, and Dr. Ridges serve as investigators for the site and are excited to offer our patients novel treatment and approaches in retinal disease.

Studies completed:
  • DRCR Protocol T
  • Allegro PVD-202
  • La Roche-BP28248
  • Orbit TG-MV-018
  • Pfizer MS B4351002
  • Pronova CTN 401613201
  • Merck MK-8931 PN017
Studies currently enrolling:
  • DRCR Protocol AB
  • DRCR Gene Study
  • Aerpio Time2b
If you are patient and interested to participate in clinical trials or If you are monitor looking for our site to participate in any new or ongoing clinical trials:

Contact Information:
Dr. Romesh
Clinical Research Coordinator
Phone: (406) 607-6699 x 111
Email: Romesh@rvcoklahoma.com